_edited.png)
The Milltrust Future Health Fund
The Future Health (FH) Fund is an early-stage venture capital fund investing globally in high-potential companies, focusing on agri-tech, healthcare, climate impact, and alternative protein.
​
The current portfolio is based acrosss UK and Singapore.
Our Verticals
The Future Health Fund follows on from the success of The British Innovation Fund, investing into high potential companies with a focus on agri-tech, the future of healthcare, climate impact, and alternative proteins, where compelling science is at the core of the commercial proposition.
Future Health Fund
Pre-Seeded Portfolio

Healthcare
52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer that rapidly identifies neutropenic sepsis, a condition that prematurely takes millions of lives each year globally.

Healthcare
Attomarker has created a unique blood testing diagnosis platform revolutionising
personalised medicine. Attomarker point of care device is now on permanent display in the Science Museum, London

Healthcare
Oncoshot applies Artificial Intelligence to provide patients with access to innovative cancer trials & therapies worldwide.

Healthcare
IRNovate's VABS is a groundbreaking, single- use device that addresses the limitations and risks of existing liver biopsy methods. It ensures enhanced safety, higher patient acceptance, faster recovery, and increased usage.

Healthcare
Jiva.ai develops a multimodal AI platform empowering healthcare organisations with tools for creating machine learning models. The platform fuses models across modalities, enhancing diagnostics and automating healthcare processes with ground-breaking results testing for prostate anomalies.

Healthcare
Eupnoos is a health-tech company that offers smartphone digital healthcare for lung health and disease detection. By applying proprietary algorithms to this audio data, the platform can identify unique biomarkers and signatures that indicate the presence of respiratory diseases, such as asthma.

Food
Cody Genetics use their unique gene editing technology to create livestock whose offspring only produce sex-biased non-GMO animals, dramatically improving animal welfare by preventing the culling of billions of animals and reducing resource-use.

Food
Roslin Technologies is a cutting-edge biotech company developing and commercialising a suite of unique animal stem cells and resources for the nascent global cultivated meat industry.









